Alcon Announces Offer for WaveLight AG

ALCON has real chance in expanding its laser refractive market share.  Getting rid of a less than optimal platform and replacing it with the Allegretto laser has excellent potential for ALCON.

Alcon has had recent problems with its LadarVision device.  Surgeons not previously exposed to the Alegretto machine have been pleasantly surprised.  The Alegretto is easy to use, fast and accurate.  While Alcon will initially compete with itself, marketing two devices, it will keep surgeons happy by offering the best technology available.

Alcon has suffered with its LADARVision system recalls and lawsuits, and has looked particularly troubled following AMO's acquisition of VISX.  Although AMO/VISX remains the market leader for refractive correction, the Allegretto represents new technology with potential advantages in terms of accuracy and speed.  Moving forward with this opportunity shows that Alcon is serious about offering...